maaf email atau password anda salah

Satu Akun, Untuk Semua Akses

Forgot Password ? Click Here

atau Masuk melalui

Google

Belum Memiliki Akun Daftar di Sini

Satu Akun, Untuk Semua Akses


Have an account? Log in here

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Satu Akun, Untuk Semua Akses

Enter your email, untuk mereset password

Konfirmasi Email

Kami telah mengirimkan link reset password melalui email ke rudihamdani@gmail.com.

Ubah No. Telepon

Ubah Password

Topik Favorit

Hapus Berita

Apakah Anda yakin akan menghapus berita?

Ubah Data Diri

Jenis Kelamin

Chasing the Deadline

Monday, December 27, 2021

The clinical trial team from Padjajaran University and their supervisors from the Food and Drug Monitoring Agency work under a tight deadline. At stake is the fate of the Covid-19 vaccination.

arsip tempo : 171162961659.

Main researcher of the Red and White vaccine clinical trial team at Airlangga University, Dominicus Husada at Dr. Soetomo Public Hospital in Surabaya, East Java, December 23. TEMPO/Aris Novia Hidayat . tempo : 171162961659.

LUCIA Rizka Andalusia remembers mid-2020 as a period of non-stop work. As director of drug registration, and later drug standardization at the Food and Drug Monitoring Agency (BPOM), she was tasked with supervising the CoronaVac clinical trial. Bio Farma handled the vaccine procurement, while the research team from Padjajaran University Medical Faculty, Bandung, West Java, was responsible with clinical trials.

Sinovac Biotech, a biopharmaceutica

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

More Articles

More exclusive contents

  • March 25, 2024

  • March 18, 2024

  • March 11, 2024

  • March 4, 2024

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe